Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Capital Employed (ROCE) | (228.7%) | (211.3%) | (306.2%) | (118.5%) | (199.6%) | (14.8%) | (5.2%) | (43.2%) | (31.6%) | (36.1%) | (41.4%) | (42.4%) | (63.8%) | (60.1%) | (65.3%) | (39.9%) | (40.0%) | (41.0%) | (37.2%) | (55.4%) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is (47.9%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Capital Employed (ROCE) for Insmed Incorporated have been (47.8%) over the past three years, and (46.2%) over the past five years.
As of today, Insmed Incorporated's Return on Capital Employed (ROCE) is (47.9%), which is higher than industry median of (51.0%). It indicates that Insmed Incorporated's Return on Capital Employed (ROCE) is Good.